iRadimed Corporation (IRMD): Price and Financial Metrics
IRMD Price/Volume Stats
Current price | $44.39 | 52-week high | $51.04 |
Prev. close | $44.27 | 52-week low | $36.12 |
Day low | $43.84 | Volume | 32,800 |
Day high | $44.78 | Avg. volume | 56,130 |
50-day MA | $44.15 | Dividend yield | 1.38% |
200-day MA | $44.68 | Market Cap | 562.11M |
IRMD Stock Price Chart Interactive Chart >
IRMD POWR Grades
- Sentiment is the dimension where IRMD ranks best; there it ranks ahead of 97.44% of US stocks.
- The strongest trend for IRMD is in Quality, which has been heading down over the past 26 weeks.
- IRMD's current lowest rank is in the Momentum metric (where it is better than 7.41% of US stocks).
IRMD Stock Summary
- The price/operating cash flow metric for IRADIMED CORP is higher than 92.46% of stocks in our set with a positive cash flow.
- With a price/sales ratio of 9.17, IRADIMED CORP has a higher such ratio than 88.29% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.17 for IRADIMED CORP; that's greater than it is for only 11.92% of US stocks.
- If you're looking for stocks that are quantitatively similar to IRADIMED CORP, a group of peers worth examining would be TNC, REZI, TAYD, OFLX, and EPC.
- IRMD's SEC filings can be seen here. And to visit IRADIMED CORP's official web site, go to www.iradimed.com.
IRMD Valuation Summary
- In comparison to the median Healthcare stock, IRMD's price/sales ratio is 126.19% higher, now standing at 9.5.
- IRMD's price/sales ratio has moved up 2.4 over the prior 115 months.
Below are key valuation metrics over time for IRMD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
IRMD | 2023-12-29 | 9.5 | 8.0 | 36.7 | 26.7 |
IRMD | 2023-12-28 | 9.2 | 7.8 | 35.6 | 25.8 |
IRMD | 2023-12-27 | 9.4 | 7.9 | 36.3 | 26.4 |
IRMD | 2023-12-26 | 9.4 | 7.9 | 36.1 | 26.2 |
IRMD | 2023-12-22 | 9.3 | 7.8 | 35.8 | 26.0 |
IRMD | 2023-12-21 | 9.2 | 7.8 | 35.5 | 25.7 |
IRMD Growth Metrics
- Its year over year net income to common stockholders growth rate is now at 956.65%.
- Its 5 year net income to common stockholders growth rate is now at 103.32%.
- The 2 year net income to common stockholders growth rate now stands at 9.11%.
The table below shows IRMD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 50.31241 | 10.36991 | 13.04754 |
2022-06-30 | 47.81244 | 9.80979 | 12.19669 |
2022-03-31 | 44.90129 | 11.74126 | 10.42534 |
2021-12-31 | 41.81458 | 11.25816 | 9.325471 |
2021-09-30 | 38.48776 | 10.38818 | 6.070218 |
2021-06-30 | 35.27956 | 8.344037 | 4.568603 |
IRMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IRMD has a Quality Grade of A, ranking ahead of 97.83% of graded US stocks.
- IRMD's asset turnover comes in at 0.488 -- ranking 96th of 186 Medical Equipment stocks.
- DYNT, NUVA, and ELMD are the stocks whose asset turnover ratios are most correlated with IRMD.
The table below shows IRMD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.488 | 0.753 | 0.283 |
2021-03-31 | 0.457 | 0.749 | 0.017 |
2020-12-31 | 0.455 | 0.743 | -0.031 |
2020-09-30 | 0.497 | 0.742 | 0.053 |
2020-06-30 | 0.545 | 0.753 | 0.144 |
2020-03-31 | 0.609 | 0.768 | 0.401 |
IRMD Price Target
For more insight on analysts targets of IRMD, see our IRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $38.00 | Average Broker Recommendation | 1.25 (Strong Buy) |
iRadimed Corporation (IRMD) Company Bio
IRadimed Corporation manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally. The company was founded in 1992 and is based in Winter Springs, Florida.
Latest IRMD News From Around the Web
Below are the latest news stories about IRADIMED CORP that investors may wish to consider to help them evaluate IRMD as an investment opportunity.
Insider Sell Alert: Director James Hawkins Sells Shares of iRadimed Corp (IRMD)In a notable insider transaction, Director James Hawkins has parted with 10,468 shares of iRadimed Corp (NASDAQ:IRMD) on December 14, 2023. |
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per shareWINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share. The special cash dividend and the quarterly dividend are payable on January 12, 2024, to shareholders of record at the close of business on December 22 |
Why We Like The Returns At IRadimed (NASDAQ:IRMD)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... |
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by ForbesForbes 2024 America's Most Successful Small Companies WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring syst |
5 Small Hidden Gems for the Rest of 2023We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX. |
IRMD Price Returns
1-mo | -2.40% |
3-mo | -1.03% |
6-mo | 2.49% |
1-year | 20.07% |
3-year | 92.04% |
5-year | 62.27% |
YTD | -6.49% |
2023 | 70.15% |
2022 | -38.78% |
2021 | 102.68% |
2020 | -2.48% |
2019 | -4.42% |
IRMD Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching IRMD
Want to see what other sources are saying about Iradimed Corp's financials and stock price? Try the links below:Iradimed Corp (IRMD) Stock Price | Nasdaq
Iradimed Corp (IRMD) Stock Quote, History and News - Yahoo Finance
Iradimed Corp (IRMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...